Archive · 19 Aug 2026
Investors Increase Bets on India’s Growing Supplements Sector
More people in India are buying health supplements to help prevent health problems and support everyday wellness.
This has made investors more interested in supplement companies.
These companies received $72 million in investment in 2026 so far, compared with $59 million in 2020.
However, the money came through fewer deals, meaning some companies received much larger investments.
Investors now want businesses to show that they can make lasting profits.
They also want products to be supported by good evidence and follow regulations.
New supplement areas include gut health, sleep, menopause, healthy ageing and weight management.
Companies are also trying programme-based approaches instead of only selling individual products.
Indian brands may do best by creating trustworthy products designed for local needs and prices.
Equity funding for India’s nutraceuticals and supplements companies reached $72 million in 2026 year-to-date.
Funding rose from $59 million in 2020, while the number of deals fell from 30 to 11.
OZiva, Cosmix, ZeroHarm Sciences and Earthful attracted investment from financial and strategic investors.
Investors are placing greater emphasis on sustainable profitability, product evidence, regulatory compliance and customer retention.
Analysts say Indian brands can compete globally through local consumer insights, credible claims, consistent quality and strong science.
- Who
- Indian nutraceutical and supplement start-ups, investors, private equity firms, strategic investors and industry analysts.
- What
- Investment in India’s health supplements sector is increasing, with larger funding checks but fewer deals.
- When
- The data covers 2026 year-to-date; the article was published on August 19, 2026.
- Where
- India.
- Why
- Investors are responding to increased interest in preventive wellness, improved scale and profitability metrics, and the emergence of new supplement categories.
- 2026 funding
- $72 million in equity funding for nutraceuticals and supplements companies, year-to-date.
- 2020 funding
- $59 million in equity funding.
- Deal count
- The number of funding rounds declined from 30 in 2020 to 11 in 2026 year-to-date.
- Funded start-ups
- OZiva, Cosmix, ZeroHarm Sciences and Earthful secured investments in 2026.
- Emerging categories
- Gut health, sleep, menopause, healthy ageing and weight management.
- Investor priorities
- Sustainable profitability, product evidence, regulatory compliance, favourable unit economics and customer retention.
- Industry challenges
- Competition from foreign brands and dependence on imports for some active ingredients, including vitamins.